Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Genome-wide DNA methylation study uncovers epigenetic markers associated with early life stress in individuals with major depressive disorder

AI Summary
  • Early life stress increases DMR burden in MDD, especially at active promoter chromatin, implicating neurodevelopmental and stress-response pathways.
  • SELENOO, FASN and THOC7 show consistent differential methylation, pointing to shared mitochondrial, metabolic and RNA-processing mechanisms in MDD.
  • MDD without ELS displays distinct hypermethylation in repressed chromatin, notably CAMK4 and CALM1, suggesting silencing of calcium-dependent neuronal signalling and synaptic plasticity.
Summarise with AI (MRCPsych/FRANZCP)

Psychiatry Clin Neurosci. 2026 Nov 13. doi: 10.1111/pcn.70166. Online ahead of print.

ABSTRACT

AIM: Early life stress (ELS) is a significant risk factor for major depressive disorder (MDD); however, the epigenetic mechanisms underlying this association remain poorly characterized, partly due to the lack of trauma-stratified control groups in previous studies.

METHODS: We performed genome-wide DNA methylation profiling using Reduced-Representative Bisulfite Sequencing (RRBS) on whole blood samples from 90 adults divided into four groups: MDD with ELS (n = 30), MDD without ELS (n = 30), controls with ELS (n = 15), and controls without ELS (n = 15). Differentially methylated regions (DMRs) were identified employing MethylKit and DMRcate (≥5 CpGs, FDR < 0.05) and annotated via FUMA GENE2FUNC and clusterProfiler.

RESULTS: Our analysis revealed 551, 581, and 479 DMRs in comparisons of MDD vs. control, MDD + ELS vs. control + ELS, and MDD non-ELS vs. control non-ELS, respectively. Core genes SELENOO, FASN, and THOC7 were consistently differentially methylated across all groups, reflecting shared mitochondrial, metabolic, and RNA-processing mechanisms. The MDD + ELS group demonstrated a higher DMR burden, particularly in regions associated with active promoter chromatin, with ELS-specific genes HIVEP3 and NRL exhibiting GWAS evidence linked to treatment-resistant depression and ADHD. Conversely, DMRs in MDD non-ELS were enriched in repressed chromatin states, with hypermethylation in loci within CAMK4 and CALM1 suggesting constitutive silencing of calcium-dependent neuronal signaling pathways. Our findings underscore the significant contribution of ELS to specific epigenetic changes associated with MDD, particularly in neurodevelopmental and stress-response pathways. In contrast, MDD without ELS exhibited a distinct methylation profile that affected synapses and synaptic plasticity.

CONCLUSION: Our study, therefore, emphasizes the necessity of trauma-informed approaches in psychiatric research.

PMID:43025855 | DOI:10.1111/pcn.70166

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD